Docosahexaenoic Acid (DHA) Market Players:
- Koninklijke DSM N.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- BASF SE
- Croda International Plc
- Cellana, Inc.
- Far East Microalgae Industries, Co., Ltd.(FEMICO)
- Pelagia AS
- Corbion NV
- JC Biotech Private Limited
- Source Omega LLC
- Shandong Yuexiang Biotechnology Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of docosahexaenoic acid is assessed at USD 5.72 billion.
The global docosahexaenoic acid market size was valued at over USD 5.25 billion in 2025 and is expected to expand at a CAGR of around 9.9%, surpassing USD 13.49 billion revenue by 2035.
The Asia Pacific region is forecasted to command a 42% share by 2035 in the docosahexaenoic acid (DHA) market, impelled by escalating healthcare expenditure that is heightening awareness of DHA’s health benefits.
Key players in the market include Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.
